BJ ENT WATER
00371
CHINA UNICOM
00762
CHINA TELECOM
00728
ABC
01288
PETROCHINA
00857
HK Stock MarketDetailed Quotes
06826 HAOHAI BIOTEC
- 27.850
- -0.650-2.28%
Not Open Dec 16 16:08 CST
6.52BMarket Cap13.67P/E (TTM)
28.500High27.350Low110.40KVolume28.500Open28.500Pre Close3.07MTurnover0.28%Turnover Ratio14.20P/E (Static)234.19MShares42.95052wk High1.04P/B1.12BFloat Cap20.49152wk Low1.23Dividend TTM40.14MShs Float104.587Historical High0.791Dividend LFY4.04%Amplitude13.033Historical Low27.766Avg Price100Lot Size4.42%Div YieldTTM2.84%Div Yield LFY
HAOHAI BIOTEC Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 4.69%2.07B | 7.00%1.4B | 5.68%646M | 25.27%2.63B | 25.23%1.98B | 36.54%1.31B | 29.06%611.25M | 20.19%2.1B | 24.14%1.58B | 13.05%956.27M |
| Operating income | 4.69%2.07B | 7.00%1.4B | 5.68%646M | 25.27%2.63B | 25.23%1.98B | 36.54%1.31B | 29.06%611.25M | 20.19%2.1B | 24.14%1.58B | 13.05%956.27M |
| Cost of sales | ---- | -9.10%-413.82M | ---- | -19.02%-781.4M | ---- | -31.02%-379.29M | ---- | -33.88%-656.52M | ---- | -33.53%-289.48M |
| Operating expenses | -9.24%-613.79M | -9.10%-413.82M | -14.13%-198.87M | -19.02%-781.4M | -18.58%-561.89M | -31.02%-379.29M | -11.54%-174.25M | -33.88%-656.52M | -44.30%-473.85M | -33.53%-289.48M |
| Gross profit | 2.90%1.46B | 6.14%983.3M | 2.32%447.12M | 28.10%1.85B | 28.07%1.42B | 38.94%926.42M | 37.68%437M | 14.86%1.45B | 17.15%1.11B | 5.99%666.78M |
| Selling expenses | 4.98%-594.49M | 3.72%-405.27M | 0.51%-199.35M | -19.86%-814.51M | -25.71%-625.68M | -34.29%-420.95M | -35.33%-200.38M | -10.97%-679.53M | -19.40%-497.72M | -23.85%-313.46M |
| Administrative expenses | -3.76%-325.24M | -4.76%-210.19M | 11.94%-82.47M | -4.20%-422.35M | 3.33%-313.46M | 7.36%-200.64M | -24.46%-93.65M | -41.67%-405.3M | -77.63%-324.26M | -97.08%-216.59M |
| Research and development expenses | -22.04%-188.14M | -23.68%-125.4M | -21.03%-64.9M | -20.81%-220.1M | -27.17%-154.15M | -32.17%-101.39M | -17.80%-53.62M | -8.71%-182.19M | -6.57%-121.22M | -4.39%-76.71M |
| Profit from asset sales | -57.97%217.99K | ---- | -9,233.48%-36.32K | ---- | 2,281.76%518.61K | ---- | -100.69%-389.15 | ---- | -132.74%-23.77K | ---- |
| Revaluation surplus | -116.05%-345.33K | ---- | -182.99%-461.1K | ---- | 192.38%2.15M | ---- | --555.64K | ---- | ---2.33M | ---- |
| -Changes in the fair value of other assets | -116.05%-345.33K | ---- | -182.99%-461.1K | ---- | 192.38%2.15M | ---- | --555.64K | ---- | ---2.33M | ---- |
| Impairment and provision | -69.47%-12.83M | 110.30%473K | 103.74%89.04K | 112.72%1.97M | 78.95%-7.57M | 46.67%-4.59M | -97.81%-2.38M | -587.62%-15.52M | -1,964.28%-35.94M | -193.83%-8.62M |
| -Other impairment is provision | -69.47%-12.83M | 110.30%473K | 103.74%89.04K | 112.72%1.97M | 78.95%-7.57M | 46.67%-4.59M | -97.81%-2.38M | -587.62%-15.52M | -1,964.28%-35.94M | -193.83%-8.62M |
| Operating interest expense | ---- | ---- | ---- | 4.05%-7.3M | ---- | ---- | ---- | -53.19%-7.6M | ---- | -60.55%-2.57M |
| Special items of operating profit | -10.17%25.23M | -50.63%26.81M | -63.44%3.87M | 54.51%116.57M | -17.33%28.09M | 15.32%54.29M | 158.75%10.58M | -59.98%75.45M | -44.84%33.98M | -45.31%47.08M |
| Operating profit | 3.76%353.45M | 6.54%269.71M | 5.05%100.66M | 118.67%507.8M | 124.27%340.65M | 163.89%253.14M | 96.90%95.82M | -38.96%232.22M | -47.41%151.89M | -65.01%95.93M |
| Financing cost | -28.92%34.08M | -104.87%-7.52M | -10.87%13.76M | ---- | -17.57%47.95M | ---3.67M | -26.29%15.44M | ---- | -13.77%58.17M | ---- |
| Share of profits of associates | ---- | -6.44%305K | ---- | 51.50%456K | ---- | 115.89%326K | ---- | 223.66%301K | ---- | 26.89%151K |
| Share of profit from joint venture company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 52.57%3.2M | ---- | --1.35M |
| Special items of earning before tax | -246.17%-1.09M | ---- | -131.68%-262.85K | ---- | 235.88%746.12K | ---- | 340.12%829.76K | ---- | 15.30%-549.11K | ---- |
| Earning before tax | -0.75%386.44M | 5.08%262.49M | 1.85%114.16M | 115.61%508.26M | 85.84%389.35M | 156.39%249.8M | 60.58%112.1M | -38.40%235.73M | -41.09%209.51M | -64.48%97.43M |
| Tax | -12.95%-70.46M | -9.06%-44.83M | 20.14%-21.68M | -111.46%-95.99M | -44.23%-62.38M | -76.16%-41.11M | -328.86%-27.14M | -28.36%-45.4M | -4.48%-43.25M | 37.49%-23.34M |
| After-tax profit from continuing operations | -3.36%315.98M | 4.30%217.66M | 8.87%92.49M | 116.61%412.27M | 96.66%326.97M | 181.67%208.69M | 33.83%84.95M | -45.19%190.33M | -47.09%166.26M | -68.73%74.09M |
| Earning after tax | -3.36%315.98M | 4.30%217.66M | 8.87%92.49M | 116.61%412.27M | 96.66%326.97M | 181.67%208.69M | 33.83%84.95M | -45.19%190.33M | -47.09%166.26M | -68.73%74.09M |
| Minority profit | -15,245.51%-24.91M | -610.57%-17.63M | -233.88%-5.05M | -139.06%-3.85M | -96.35%164.45K | 12.81%3.45M | 48.85%3.77M | 299.17%9.86M | 20.77%4.51M | -48.25%3.06M |
| Profit attributable to shareholders | 4.31%340.89M | 14.64%235.28M | 20.16%97.54M | 130.58%416.12M | 102.04%326.8M | 188.94%205.24M | 33.21%81.18M | -48.76%180.47M | -47.91%161.75M | -69.25%71.03M |
| Basic earnings per share | 6.57%1.46 | 17.44%1.01 | 23.40%0.58 | 134.62%2.44 | 47.31%1.37 | 109.76%0.86 | 34.29%0.47 | -48.00%1.04 | -47.16%0.93 | -68.70%0.41 |
| Diluted earnings per share | 6.57%1.46 | 17.44%1.01 | 23.40%0.58 | 134.62%2.44 | 47.31%1.37 | 109.76%0.86 | 34.29%0.47 | -48.00%1.04 | -47.16%0.93 | -68.70%0.41 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Trending HK Stocks
HK Dividend Stocks HK Dividend Stocks
Dividend stocks are stocks of companies in the HK stock market that regularly distribute dividends to shareholders, generally representing stable businesses. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK dividend stocks, ranked from highest to lowest based on real-time market data. Dividend stocks are stocks of companies in the HK stock market that regularly distribute dividends to shareholders, generally representing stable businesses. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK dividend stocks, ranked from highest to lowest based on real-time market data.
